Alzheimer’s disease disproportionately affects women, whether as patients or caregivers. “But do women deserve to bear this unequal burden?” This is the critical question the Women’s Brain Foundation (WBF) is inviting all stakeholders to reflect upon through its newly-launched campaign aimed at raising awareness and supporting research on sex and gender considerations in Alzheimer’s disease clinical development. WBF’s scientific work highlights how sex and gender differences impact even key clinical outcomes, such as the Clinical Dementia Rating-Sum of Boxes (CDR-SB), as demonstrated in their recent publication in the journal Nature Aging. By addressing these disparities, the Foundation aims to transform Alzheimer’s research and care to better serve women globally. Through this campaign, WBF is calling for collaborative action across academia, industry, regulatory bodies, and patient organisations to create a more equitable and effective approach to Alzheimer’s disease management. Find out more about WBF, via:
